|
|
Volumn 14, Issue 12, 1996, Pages 3053-3055
|
|
Topotecan today
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
ETOPOSIDE;
GRANULOCYTE COLONY STIMULATING FACTOR;
HEMOPOIETIC GROWTH FACTOR;
PACLITAXEL;
TOPOTECAN;
BLOOD TOXICITY;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CLINICAL TRIAL;
DRUG APPROVAL;
DRUG RESPONSE;
EDITORIAL;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG SMALL CELL CANCER;
NEUTROPENIA;
OVARY CANCER;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
|
|
EID: 0029857114
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.1996.14.12.3053 Document Type: Editorial |
|
Times cited : (14)
|
|
References (0)
|
